Quantcast

Latest Angiogenesis Stories

2011-07-07 19:25:41

Scientists at the University of Southampton have developed smart nanomaterials, which can disrupt the blood supply to cancerous tumors. The team of researchers, led by Physics lecturer Dr Antonios Kanaras, showed that a small dose of gold nanoparticles can activate or inhibit genes that are involved in angiogenesis - a complex process responsible for the supply of oxygen and nutrients to most types of cancer. "The peptide-functionalized gold nanoparticles that we synthesized are very...

2011-07-02 02:29:20

Natural plant compound blocks vessel growth by interfering with cellular adhesion Massachusetts General Hospital (MGH) researchers have discovered the first of an entirely new class of antiangiogenesis drugs "“ agents that interfere with the development of blood vessels. In a report in Proceedings of the National Academy of Sciences/Early Edition, the investigators describe how a compound derived from a South American tree was able, through a novel mechanism, to interfere with blood...

2011-06-23 07:30:00

BARCELONA, Spain, June 23, 2011 /PRNewswire/ -- CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented pre-clinical research results at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer in Barcelona, Spain demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor...

2011-06-22 08:00:00

SAN DIEGO, June 22, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced the selection of the Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los Angeles, California, to serve as the central core lab for the Company's Generx ASPIRE clinical study. Cedars-Sinai Core Laboratory will be responsible for the consolidation and analysis of SPECT (single-photon emission computed tomography) myocardial imaging data from the...

2011-06-17 06:05:00

TARRYTOWN, N.Y., June 17, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that NASDAQ has halted trading of the company's common stock today. The Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is meeting today to discuss the company's Biologics License Application (BLA) for EYLEA(TM), also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD)....

2011-06-15 08:00:00

SAN DIEGO, June 15, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has received clearance from the Russian Ministry of Health and Social Development to commence a Phase 3 registration study for the Company's Generx(TM) (alferminogene tadenovec, Ad5FGF-4) biologic product candidate. Generx is a new and innovative DNA-based angiogenic therapy designed for the potential treatment of myocardial ischemia due to coronary artery disease. The Russian Health...

2011-06-10 06:37:43

(Ivanhoe Newswire) -- Proteins found in frog skin may be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels, according to new research. Investigators from Queen's University Belfast identified two proteins that can be used to regulate angiogenesis, which is the process by which blood vessels grow in the body. They say this discovery could potentially help them develop new treatments for more than 70 major diseases and conditions that...

2011-06-07 15:12:56

Blocking two tiny molecules of RNA "“ a chemical cousin of DNA "“ appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found. Their findings, available in the Proceedings of the National Academy of Sciences, suggest a potential strategy to treat age-related macular degeneration (AMD), a vascular eye disorder that affects nearly 2 million Americans and is a leading cause of blindness...

85401381d49ee0c286badb66b8225092
2011-06-07 14:25:00

Scientists at Queen's University Belfast have discovered that proteins in frog skins could be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels. The researchers identified two proteins, or "peptides", which can be used in a controlled and targeted way to regulate "angiogenesis."  The discovery holds the potential to develop new treatments for more than seventy major diseases and conditions that affect over a billion people...

2011-06-06 18:38:00

MELBOURNE, Australia, June 6, 2011 /PRNewswire/ -- Circadian Technologies Limited (ASX: CIR) announced today the presentation of data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago USA associating resistance to Avastin® with increases in plasma VEGF-C and D concentrations. The poster presentation entitled "The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer (mCRC)" is available on...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related